Clinical trials
Not yet recruiting Phase 2 Leukemia, Myeloid, Acute trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
47 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 2 |
| 2024 | 7 |
| 2025 | 7 |
| 2026 | 27 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 47 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| Institute of Hematology & Blood Diseases Hospital, China | 3 |
| Ruijin Hospital | 3 |
| Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | 2 |
| Navy General Hospital, Beijing | 2 |
| The First Affiliated Hospital of Soochow University | 2 |
| University of Rochester | 2 |
| Antonio Pierini | 1 |
| Center for International Blood and Marrow Transplant Research | 1 |
| Dongguan People's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 47 |
| Myelodysplastic Syndromes | 10 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 |
| Myeloproliferative Disorders | 3 |
| Recurrence | 3 |
| Anemia, Refractory, with Excess of Blasts | 1 |
| Blastic Plasmacytoid Dendritic Cell Neoplasm | 1 |
| Burkitt Lymphoma | 1 |
| Disease | 1 |
| Leukemia, Biphenotypic, Acute | 1 |
Trials
Showing 1 to 25 of 47. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.